{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T02:02:38Z","timestamp":1793325758912,"version":"4.5.0"},"reference-count":100,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JASN"],"published-print":{"date-parts":[[2018,1]]},"abstract":"<jats:p>\n                    Data indicate significant phenotypic and genotypic overlap, plus a common pathogenesis, between two groups of inherited disorders, autosomal dominant polycystic kidney diseases (ADPKD), a significant cause of ESRD, and autosomal dominant polycystic liver diseases (ADPLD), which result in significant PLD with minimal PKD. Eight genes have been associated with ADPKD (\n                    <jats:italic toggle=\"yes\">PKD1<\/jats:italic>\n                    and\n                    <jats:italic toggle=\"yes\">PKD2<\/jats:italic>\n                    ), ADPLD (\n                    <jats:italic toggle=\"yes\">PRKCSH<\/jats:italic>\n                    ,\n                    <jats:italic toggle=\"yes\">SEC63<\/jats:italic>\n                    ,\n                    <jats:italic toggle=\"yes\">LRP5<\/jats:italic>\n                    ,\n                    <jats:italic toggle=\"yes\">ALG8<\/jats:italic>\n                    , and\n                    <jats:italic toggle=\"yes\">SEC61B<\/jats:italic>\n                    ), or both (\n                    <jats:italic toggle=\"yes\">GANAB<\/jats:italic>\n                    ). Although genetics is only infrequently used for diagnosing these diseases and prognosing the associated outcomes, its value is beginning to be appreciated, and the genomics revolution promises more reliable and less expensive molecular diagnostic tools for these diseases. We therefore propose categorization of patients with a phenotypic and genotypic descriptor that will clarify etiology, provide prognostic information, and better describe atypical cases. In genetically defined cases, the designation would include the disease and gene names, with allelic (truncating\/nontruncating) information included for\n                    <jats:italic toggle=\"yes\">PKD1<\/jats:italic>\n                    . Recent data have shown that biallelic disease including at least one weak ADPKD allele is a significant cause of symptomatic, very early onset ADPKD. Including a genic (and allelic) descriptor with the disease name will provide outcome clues, guide treatment, and aid prevalence estimates.\n                  <\/jats:p>","DOI":"10.1681\/asn.2017050483","type":"journal-article","created":{"date-parts":[[2017,10,16]],"date-time":"2017-10-16T20:40:23Z","timestamp":1508186423000},"page":"13-23","source":"Crossref","is-referenced-by-count":360,"title":["Genetic Complexity of Autosomal Dominant Polycystic Kidney and Liver Diseases"],"prefix":"10.1681","volume":"29","author":[{"given":"Emilie","family":"Cornec-Le Gall","sequence":"first","affiliation":[{"name":"Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota; and"},{"name":"Department of Nephrology, University Hospital, European University of Brittany, and National Institute of Health and Medical Sciences, INSERM U1078, Brest, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente E.","family":"Torres","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C.","family":"Harris","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2017,10,16]]},"reference":[{"key":"B1-20230819","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/S0140-6736(15)60907-2","article-title":"Autosomal dominant polycystic kidney disease: The changing face of clinical management.","volume":"385","author":"Ong","year":"2015","journal-title":"Lancet"},{"key":"B2-20230819","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1038\/ki.1992.195","article-title":"Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease.","volume":"41","author":"Gabow","year":"1992","journal-title":"Kidney Int"},{"key":"B3-20230819","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1681\/ASN.2012070650","article-title":"Type of PKD1 mutation influences renal outcome in ADPKD.","volume":"24","author":"Cornec-Le Gall","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"B4-20230819","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1681\/ASN.2014101051","article-title":"Comprehensive PKD1 and PKD2 mutation analysis in prenatal autosomal dominant polycystic kidney disease.","volume":"27","author":"Audr\u00e9zet","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"B5-20230819","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1681\/ASN.V3121863","article-title":"Characteristics of very early onset autosomal dominant polycystic kidney disease.","volume":"3","author":"Fick","year":"1993","journal-title":"J Am Soc Nephrol"},{"key":"B6-20230819","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1136\/jmg.30.7.583","article-title":"German working group on paediatric nephrology: Childhood onset autosomal dominant polycystic kidney disease in sibs: Clinical picture and recurrence risk.","volume":"30","author":"Zerres","year":"1993","journal-title":"J Med Genet"},{"key":"B7-20230819","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.cgh.2014.07.051","article-title":"Liver involvement in early autosomal-dominant polycystic kidney disease.","volume":"13","author":"Hogan","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B8-20230819","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1093\/ndt\/gfw008","article-title":"Effect of genotype on the severity and volume progression of polycystic liver disease in ADPKD.","volume":"31","author":"Chebib","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"B9-20230819","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1750-1172-9-69","article-title":"Polycystic liver disease: An overview of pathogenesis, clinical manifestations and management.","volume":"9","author":"Cnossen","year":"2014","journal-title":"Orphanet J Rare Dis"},{"key":"B10-20230819","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/0092-8674(94)90137-6","article-title":"The polycystic kidney disease 1 gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16.","volume":"77","year":"1994","journal-title":"Cell"},{"key":"B11-20230819","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0092-8674(95)90339-9","article-title":"Polycystic kidney disease: The complete structure of the PKD1 gene and its protein.","volume":"81","year":"1995","journal-title":"Cell"},{"key":"B12-20230819","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/ng0695-151","article-title":"The polycystic kidney disease 1 (PKD1) gene encodes a novel protein with multiple cell recognition domains.","volume":"10","author":"Hughes","year":"1995","journal-title":"Nat Genet"},{"key":"B13-20230819","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1126\/science.272.5266.1339","article-title":"PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein.","volume":"272","author":"Mochizuki","year":"1996","journal-title":"Science"},{"key":"B14-20230819","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1681\/ASN.2015050583","article-title":"Predicted mutation strength of nontruncating PKD1 mutations aids genotype-phenotype correlations in autosomal dominant polycystic kidney disease.","volume":"27","author":"Heyer","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"B15-20230819","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.ajhg.2016.05.004","article-title":"Mutations in GANAB, encoding the glucosidase IIalpha subunit, cause autosomal-dominant polycystic kidney and liver disease.","volume":"98","author":"Porath","year":"2016","journal-title":"Am J Hum Genet"},{"key":"B16-20230819","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ng1104","article-title":"Germline mutations in PRKCSH are associated with autosomal dominant polycystic liver disease.","volume":"33","author":"Drenth","year":"2003","journal-title":"Nat Genet"},{"key":"B17-20230819","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1086\/368295","article-title":"Mutations in PRKCSH cause isolated autosomal dominant polycystic liver disease.","volume":"72","author":"Li","year":"2003","journal-title":"Am J Hum Genet"},{"key":"B18-20230819","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/ng1357","article-title":"Mutations in SEC63 cause autosomal dominant polycystic liver disease.","volume":"36","author":"Davila","year":"2004","journal-title":"Nat Genet"},{"key":"B19-20230819","doi-asserted-by":"crossref","first-page":"5343","DOI":"10.1073\/pnas.1309438111","article-title":"Whole-exome sequencing reveals LRP5 mutations and canonical Wnt signaling associated with hepatic cystogenesis.","volume":"111","author":"Cnossen","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B20-20230819","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1172\/JCI90129","article-title":"Isolated polycystic liver disease genes define effectors of polycystin-1 function.","volume":"127","author":"Besse","year":"2017","journal-title":"J Clin Invest"},{"key":"B21-20230819","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0140-6736(98)03495-3","article-title":"Comparison of phenotypes of polycystic kidney disease types 1 and 2. European PKD1-PKD2 Study Group.","volume":"353","author":"Hateboer","year":"1999","journal-title":"Lancet"},{"key":"B22-20230819","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1056\/NEJMoa054341","article-title":"Volume progression in polycystic kidney disease.","volume":"354","author":"Grantham","year":"2006","journal-title":"N Engl J Med"},{"key":"B23-20230819","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1681\/ASN.2006080835","article-title":"Cyst number but not the rate of cystic growth is associated with the mutated gene in ADPKD.","volume":"17","author":"Harris","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"B24-20230819","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/ki.2015.207","article-title":"A polycystin-centric view of cyst formation and disease: The polycystins revisited.","volume":"88","author":"Ong","year":"2015","journal-title":"Kidney Int"},{"key":"B25-20230819","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jhep.2009.12.011","article-title":"Congenital disorders of glycosylation in hepatology: The example of polycystic liver disease.","volume":"52","author":"Janssen","year":"2010","journal-title":"J Hepatol"},{"key":"B26-20230819","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/ng.860","article-title":"A genetic interaction network of five genes for human polycystic kidney and liver diseases defines polycystin-1 as the central determinant of cyst formation.","volume":"43","author":"Fedeles","year":"2011","journal-title":"Nat Genet"},{"key":"B27-20230819","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.molmed.2014.01.004","article-title":"Polycystin-1: A master regulator of intersecting cystic pathways.","volume":"20","author":"Fedeles","year":"2014","journal-title":"Trends Mol Med"},{"key":"B28-20230819","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S2213-2600(16)00053-9","article-title":"Newborn screening for cystic fibrosis.","volume":"4","author":"Castellani","year":"2016","journal-title":"Lancet Respir Med"},{"key":"B29-20230819","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1091\/mbc.e14-04-0935","article-title":"From CFTR biology toward combinatorial pharmacotherapy: Expanded classification of cystic fibrosis mutations.","volume":"27","author":"Veit","year":"2016","journal-title":"Mol Biol Cell"},{"key":"B30-20230819","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/nrneph.2016.87","article-title":"The expanding phenotypic spectra of kidney diseases: Insights from genetic studies.","volume":"12","author":"Stokman","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"B31-20230819","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1681\/ASN.2008050507","article-title":"Unified criteria for ultrasonographic diagnosis of ADPKD.","volume":"20","author":"Pei","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"B32-20230819","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1681\/ASN.2014030297","article-title":"Imaging-based diagnosis of autosomal dominant polycystic kidney disease.","volume":"26","author":"Pei","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"B33-20230819","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1681\/ASN.2013101138","article-title":"Imaging classification of autosomal dominant polycystic kidney disease: A simple model for selecting patients for clinical trials.","volume":"26","author":"Irazabal","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"B34-20230819","article-title":"Image texture features predict renal function decline in patients with autosomal dominant polycystic kidney disease [published online ahead of print May 20, 2017].","author":"Kline","journal-title":"Kidney Int"},{"key":"B35-20230819","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrg.2016.162","article-title":"Evolving health care through personal genomics.","volume":"18","author":"Rehm","year":"2017","journal-title":"Nat Rev Genet"},{"key":"B36-20230819","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1681\/ASN.2015010016","article-title":"The PROPKD score: A new algorithm to predict renal survival in autosomal dominant polycystic kidney disease.","volume":"27","author":"Cornec-Le Gall","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"B37-20230819","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1053\/j.ajkd.2011.12.022","article-title":"Characteristics of renal cystic and solid lesions based on contrast-enhanced computed tomography of potential kidney donors.","volume":"59","author":"Rule","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"B38-20230819","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1148\/radiol.2213010178","article-title":"Rapid MR imaging detection of renal cysts: Age-based standards.","volume":"221","author":"Nascimento","year":"2001","journal-title":"Radiology"},{"key":"B39-20230819","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1086\/316939","article-title":"Mutation analysis of the entire PKD1 gene: Genetic and diagnostic implications.","volume":"68","author":"Rossetti","year":"2001","journal-title":"Am J Hum Genet"},{"key":"B40-20230819","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1681\/ASN.2016090938","article-title":"Polycystic kidney disease without an apparent family history.","volume":"28","author":"Iliuta","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"B41-20230819","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/ki.2008.686","article-title":"Incompletely penetrant PKD1 alleles suggest a role for gene dosage in cyst initiation in polycystic kidney disease.","volume":"75","author":"Rossetti","year":"2009","journal-title":"Kidney Int"},{"key":"B42-20230819","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1681\/ASN.2009101070","article-title":"Incompletely penetrant PKD1 alleles mimic the renal manifestations of ARPKD.","volume":"21","author":"Vujic","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"B43-20230819","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1681\/ASN.2010101080","article-title":"Mutations in multiple PKD genes may explain early and severe polycystic kidney disease.","volume":"22","author":"Bergmann","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"B44-20230819","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1007\/s00467-013-2484-x","article-title":"Bilineal inheritance of PKD1 abnormalities mimicking autosomal recessive polycystic disease.","volume":"28","author":"Gilbert","year":"2013","journal-title":"Pediatr Nephrol"},{"key":"B45-20230819","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s00467-017-3584-9","article-title":"Tolvaptan treatment for severe neonatal autosomal-dominant polycystic kidney disease.","volume":"32","author":"Gilbert","year":"2017","journal-title":"Pediatr Nephrol"},{"key":"B46-20230819","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1006\/geno.1999.5927","article-title":"Genome duplications and other features in 12 Mb of DNA sequence from human chromosome 16p and 16q.","volume":"60","author":"Loftus","year":"1999","journal-title":"Genomics"},{"key":"B47-20230819","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1093\/molbev\/msn202","article-title":"How segmental duplications shape our genome: Recent evolution of ABCC6 and PKD1 Mendelian disease genes.","volume":"25","author":"Symmons","year":"2008","journal-title":"Mol Biol Evol"},{"key":"B48-20230819","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1002\/humu.22708","article-title":"Genetics and pathogenesis of autosomal dominant polycystic kidney disease: 20 years on.","volume":"35","author":"Cornec-Le Gall","year":"2014","journal-title":"Hum Mutat"},{"key":"B49-20230819","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1681\/ASN.V125955","article-title":"Mutation analysis of the entire replicated portion of PKD1 using genomic DNA samples.","volume":"12","author":"Phakdeekitcharoen","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"B50-20230819","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nrneph.2010.18","article-title":"Molecular diagnostics for autosomal dominant polycystic kidney disease.","volume":"6","author":"Harris","year":"2010","journal-title":"Nat Rev Nephrol"},{"key":"B51-20230819","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1681\/ASN.2011101032","article-title":"Identification of gene mutations in autosomal dominant polycystic kidney disease through targeted resequencing.","volume":"23","author":"Rossetti","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"B52-20230819","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/mgg3.82","article-title":"Diagnosis of autosomal dominant polycystic kidney disease using efficient PKD1 and PKD2 targeted next-generation sequencing.","volume":"2","author":"Trujillano","year":"2014","journal-title":"Mol Genet Genomic Med"},{"key":"B53-20230819","doi-asserted-by":"crossref","first-page":"e0116680","DOI":"10.1371\/journal.pone.0116680","article-title":"An efficient and comprehensive strategy for genetic diagnostics of polycystic kidney disease.","volume":"10","author":"Eisenberger","year":"2015","journal-title":"PLoS One"},{"key":"B54-20230819","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.1172\/JCI64313","article-title":"Functional polycystin-1 dosage governs autosomal dominant polycystic kidney disease severity.","volume":"122","author":"Hopp","year":"2012","journal-title":"J Clin Invest"},{"key":"B55-20230819","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1681\/ASN.2015060648","article-title":"Refining genotype-phenotype correlation in autosomal dominant polycystic kidney disease.","volume":"27","author":"Hwang","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"B57-20230819","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"B58-20230819","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/ki.2015.28","article-title":"Autosomal dominant tubulointerstitial kidney disease: Diagnosis, classification, and management--A KDIGO consensus report.","volume":"88","author":"Eckardt","year":"2015","journal-title":"Kidney Int"},{"key":"B59-20230819","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1097\/01.ASN.0000013300.11876.37","article-title":"The position of the polycystic kidney disease 1 (PKD1) gene mutation correlates with the severity of renal disease.","volume":"13","author":"Rossetti","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"B60-20230819","doi-asserted-by":"crossref","first-page":"5129","DOI":"10.1172\/JCI67273","article-title":"Altered trafficking and stability of polycystins underlie polycystic kidney disease.","volume":"124","author":"Cai","year":"2014","journal-title":"J Clin Invest"},{"key":"B61-20230819","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1172\/JCI76972","article-title":"Polycystin-1 maturation requires polycystin-2 in a dose-dependent manner.","volume":"125","author":"Gainullin","year":"2015","journal-title":"J Clin Invest"},{"key":"B62-20230819","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1053\/j.ajkd.2010.02.349","article-title":"Renal ultrasonographic evaluation in children at risk of autosomal dominant polycystic kidney disease.","volume":"56","author":"Reed","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"B63-20230819","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1111\/j.1523-1755.2005.00678.x","article-title":"Autosomal-dominant polycystic kidney disease in infancy and childhood: Progression and outcome.","volume":"68","author":"Shamshirsaz","year":"2005","journal-title":"Kidney Int"},{"key":"B64-20230819","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000448695","article-title":"Long-term outcomes in patients with very-early onset autosomal dominant polycystic kidney disease.","volume":"44","author":"Nowak","year":"2016","journal-title":"Am J Nephrol"},{"key":"B65-20230819","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1136\/jmedgenet-2011-100452","article-title":"Neonatal onset autosomal dominant polycystic kidney disease (ADPKD) in a patient homozygous for a PKD2 missense mutation due to uniparental disomy.","volume":"49","author":"Losekoot","year":"2012","journal-title":"J Med Genet"},{"key":"B66-20230819","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/ng1097-179","article-title":"Perinatal lethality with kidney and pancreas defects in mice with a targetted Pkd1 mutation.","volume":"17","author":"Lu","year":"1997","journal-title":"Nat Genet"},{"key":"B67-20230819","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/71724","article-title":"Cardiac defects and renal failure in mice with targeted mutations in Pkd2.","volume":"24","author":"Wu","year":"2000","journal-title":"Nat Genet"},{"key":"B68-20230819","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1681\/ASN.2010030328","article-title":"What is the role of somatic mutation in autosomal dominant polycystic kidney disease?","volume":"21","author":"Harris","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"B69-20230819","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1053\/j.ackd.2010.01.002","article-title":"Molecular advances in autosomal dominant polycystic kidney disease.","volume":"17","author":"Gallagher","year":"2010","journal-title":"Adv Chronic Kidney Dis"},{"key":"B70-20230819","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1086\/318188","article-title":"Bilineal disease and trans-heterozygotes in autosomal dominant polycystic kidney disease.","volume":"68","author":"Pei","year":"2001","journal-title":"Am J Hum Genet"},{"key":"B71-20230819","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/ki.2011.370","article-title":"A missense mutation in PKD1 attenuates the severity of renal disease.","volume":"81","author":"Pei","year":"2012","journal-title":"Kidney Int"},{"key":"B72-20230819","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/ng1294-328","article-title":"Deletion of the TSC2 and PKD1 genes associated with severe infantile polycystic kidney disease--a contiguous gene syndrome.","volume":"8","author":"Brook-Carter","year":"1994","journal-title":"Nat Genet"},{"key":"B73-20230819","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1038\/ki.2008.485","article-title":"Characterization of large rearrangements in autosomal dominant polycystic kidney disease and the PKD1\/TSC2 contiguous gene syndrome.","volume":"74","author":"Consugar","year":"2008","journal-title":"Kidney Int"},{"key":"B74-20230819","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1086\/514888","article-title":"Renal cystic disease in tuberous sclerosis: Role of the polycystic kidney disease 1 gene.","volume":"61","author":"Sampson","year":"1997","journal-title":"Am J Hum Genet"},{"key":"B75-20230819","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.md.0000200165.90373.9a","article-title":"Clinical and molecular characterization defines a broadened spectrum of autosomal recessive polycystic kidney disease (ARPKD).","volume":"85","author":"Adeva","year":"2006","journal-title":"Medicine (Baltimore)"},{"key":"B76-20230819","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.ymgme.2011.09.001","article-title":"Hepatorenal findings in obligate heterozygotes for autosomal recessive polycystic kidney disease.","volume":"104","author":"Gunay-Aygun","year":"2011","journal-title":"Mol Genet Metab"},{"key":"B77-20230819","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1681\/ASN.2016121312","article-title":"Polycystic kidney disease with hyperinsulinemic hypoglycemia caused by a promoter mutation in phosphomannomutase 2.","volume":"28","author":"Cabezas","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"B78-20230819","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/ki.2014.72","article-title":"Renal fibrosis is the common feature of autosomal dominant tubulointerstitial kidney diseases caused by mutations in mucin 1 or uromodulin.","volume":"86","author":"Ekici","year":"2014","journal-title":"Kidney Int"},{"key":"B79-20230819","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1681\/ASN.2015050544","article-title":"Hepatocyte nuclear factor 1\u03b2-associated kidney disease: More than renal cysts and diabetes.","volume":"27","author":"Verhave","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"B80-20230819","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ajhg.2016.05.028","article-title":"Heterozygous loss-of-function SEC61A1 mutations cause autosomal-dominant tubulo-interstitial and glomerulocystic kidney disease with anemia.","volume":"99","author":"Bolar","year":"2016","journal-title":"Am J Hum Genet"},{"key":"B81-20230819","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1056\/NEJMoa071906","article-title":"COL4A1 mutations and hereditary angiopathy, nephropathy, aneurysms, and muscle cramps.","volume":"357","author":"Plaisier","year":"2007","journal-title":"N Engl J Med"},{"key":"B82-20230819","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1002\/humu.20792","article-title":"Mutational spectrum of the oral-facial-digital type I syndrome: A study on a large collection of patients.","volume":"29","author":"Prattichizzo","year":"2008","journal-title":"Hum Mutat"},{"key":"B83-20230819","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1136\/jmg.2004.027672","article-title":"Clinical, molecular, and genotype-phenotype correlation studies from 25 cases of oral-facial-digital syndrome type 1: A French and Belgian collaborative study.","volume":"43","author":"Thauvin-Robinet","year":"2006","journal-title":"J Med Genet"},{"key":"B85-20230819","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1097\/01.ASN.0000061774.90975.25","article-title":"Genotype-renal function correlation in type 2 autosomal dominant polycystic kidney disease.","volume":"14","author":"Magistroni","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"B86-20230819","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1681\/ASN.2013040417","article-title":"The mutation, a key determinant of phenotype in ADPKD.","volume":"24","author":"Harris","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"B87-20230819","first-page":"766A","article-title":"High-throughput, comparative variant profiling aids molecular diagnostics of ADPKD.","volume":"27","author":"Gainullin","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"B88-20230819","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1600-6143.2007.02030.x","article-title":"Mosaicism in autosomal dominant polycystic kidney disease revealed by genetic testing to enable living related renal transplantation.","volume":"8","author":"Connor","year":"2008","journal-title":"Am J Transplant"},{"key":"B89-20230819","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1471-2369-14-59","article-title":"Autosomal dominant polycystic kidney disease in a family with mosaicism and hypomorphic allele.","volume":"14","author":"Reiterov\u00e1","year":"2013","journal-title":"BMC Nephrol"},{"key":"B90-20230819","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/cge.12383","article-title":"Autosomal dominant polycystic kidney disease caused by somatic and germline mosaicism.","volume":"87","author":"Tan","year":"2015","journal-title":"Clin Genet"},{"key":"B91-20230819","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/ki.2014.432","article-title":"Rare inherited disorders with renal involvement-approach to the patient.","volume":"87","author":"Joly","year":"2015","journal-title":"Kidney Int"},{"key":"B92-20230819","first-page":"1","article-title":"Bilateral polycystic disease of the kidneys; a follow-up of two hundred and eighty-four patients and their families.","volume":"328","author":"Dalgaard","year":"1957","journal-title":"Acta Med Scand Suppl"},{"key":"B93-20230819","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S0272-6386(83)80044-4","article-title":"Epidemiology of adult polycystic kidney disease, Olmsted County, Minnesota: 1935-1980.","volume":"2","author":"Iglesias","year":"1983","journal-title":"Am J Kidney Dis"},{"key":"B94-20230819","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1093\/ndt\/gfs551","article-title":"Epidemiology of autosomal-dominant polycystic kidney disease: An in-depth clinical study for south-western Germany.","volume":"28","author":"Neumann","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"B95-20230819","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1053\/j.ajkd.2011.01.023","article-title":"Use of antihypertensive medications and mortality of patients with autosomal dominant polycystic kidney disease: A population-based study.","volume":"57","author":"Patch","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"B96-20230819","first-page":"1356","article-title":"Prevalence of autosomal dominant polycystic kidney disease in the European Union.","volume":"32","author":"Willey","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"B97-20230819","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1053\/j.ajkd.2017.01.046","article-title":"PKD2-related autosomal dominant polycystic kidney disease: Prevalence, clinical presentation, mutation spectrum, and prognosis.","volume":"70","author":"Cornec-Le Gall","year":"2017","journal-title":"Am J Kidney Dis"},{"key":"B98-20230819","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1478-3231.2010.02247.x","article-title":"Patients with isolated polycystic liver disease referred to liver centres: Clinical characterization of 137 cases.","volume":"31","author":"Van Keimpema","year":"2011","journal-title":"Liver Int"},{"key":"B100-20230819","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1378\/chest.12-1639","article-title":"Cystic fibrosis therapeutics: The road ahead.","volume":"143","author":"Hoffman","year":"2013","journal-title":"Chest"},{"key":"B101-20230819","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1681\/ASN.2009020162","article-title":"Family history of renal disease severity predicts the mutated gene in ADPKD.","volume":"20","author":"Barua","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"B102-20230819","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1681\/ASN.2008030287","article-title":"New equations to estimate GFR in children with CKD.","volume":"20","author":"Schwartz","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"B103-20230819","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12882-015-0015-7","article-title":"A novel PKD1 variant demonstrates a disease-modifying role in trans with a truncating PKD1 mutation in patients with autosomal dominant polycystic kidney disease.","volume":"16","author":"Ali","year":"2015","journal-title":"BMC Nephrol"}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001751-201801000-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:29:59Z","timestamp":1786130999000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001751-201801000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,16]]},"references-count":100,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.2017050483","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.732006358.793555201","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.732006358.793550560","asserted-by":"object"}]},"ISSN":["1046-6673","1533-3450"],"issn-type":[{"value":"1046-6673","type":"print"},{"value":"1533-3450","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,16]]}}}